Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell ...

From juggling a demanding career with family life to facing a frightening diagnosis, Norah O'Donnell's rise to the top hasn't been without tragedy.

Basal cell carcinoma is the most common skin cancer, often caused by UV exposure, and originates in the epidermis's basal cells. Diagnosis involves clinical examination and biopsy to confirm BCC and ...

Dermatologist reviewed: Natalie Matthews, MD, MPhil, FAAD; Rajiv I. Nijhawan, MD, FACMS, FAAD; and Darrell S. Rigel, MD, FAAD. Reviewer bios. What is the outcome for a person who has basal cell ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." LOW BACK PAIN is more than just discomfort. It's the leading cause of disability worldwide according to ...

CLEVELAND CLINIC ABU DHABI (CCAD) HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 8, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” ...

Reston, VA (August 21, 2025)--A topical fluorescent molecular contrast agent, PARPi-FL, can detect basal cell carcinoma through intact skin in as little as five minutes in ex vivo human tissues, ...

Amanda Anderson, 43, received the diagnosis in June after first noticing a "small irritated spot" on her nose in January Becca Longmire is a digital news writer-reporter at PEOPLE. She has been ...